Skip to content

Clinical Hemodynamic Study of Balloon Counterpulsation in Advanced Heart Failure

Clinical Hemodynamic Study of Balloon Counterpulsation in Advanced Heart Failure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03001674
Enrollment
15
Registered
2016-12-23
Start date
2014-12-31
Completion date
2015-12-31
Last updated
2017-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The primary objective of this study is to develop normative hemodynamic data (means and standard deviations) for the intra-aortic balloon pump (IABP) using pressure-volume loop and 3D-echocardiographic analyses.

Interventions

DEVICEConductance catheterization

CD Leycom Conductance Catheter

Sponsors

Tufts Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or females between 18-75 years of age * NYHA Class III-IV heart failure at the time of MEGA deployment * Stage C-D systolic heart failure * Non-ischemic cardiomyopathy * Preserved right ventricular function defined by 2D-echocardiography * Clinically indicated left and right heart catheterization and MEGA-IABP placement * Clinically indicated MEGA-IABP support for 12 hours minimum

Exclusion criteria

* Ischemic cardiomyopathy * Active myocardial ischemia or acute coronary syndrome * Severe peripheral vascular disease * Severe aortic or mitral valve insufficiency * Severe aortic or mitral valve stenosis * Right ventricular failure * Inability to tolerate left and right heart catheterization * Severe hemodynamic instability defined as a systolic BP \<80mmHg despite vasopressor/inotropic support * Sustained ventricular tachycardia (\>10 beats) within 24 hours and/or ventricular fibrillation within 24 hours * Pacemaker dependent rhythm * Left ventricular thrombus * Rapid atrial fibrillation (HR\>120 bpm) * Unable to provide informed consent * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Impact of Intra-aortic Balloon Pump Activation on Left Ventricular Stroke Work.24 hoursWe will be measuring left ventricular stroke work using a conductance catheter before and immediately after activation of an intra-aortic balloon pump (IABP). Left ventricular stroke work is quantified as the product of left ventricular pressure and volume. Conductance catheters are the primary method available for clinical measurement of left ventricular volume and pressure.

Countries

United States

Participant flow

Recruitment details

10 patients with advanced HF from 2014 to 2015 at Tufts Medical Center referred for clinically indicated RHC and IABP placement prior to LVAD surgery. Five control subjects undergoing left heart catheterization with an LV ejection fraction \> 50%, and without a history of heart failure symptoms who did not receive IABP therapy were enrolled.

Participants by arm

ArmCount
IABP Recipient
Conductance catheterization: CD Leycom Conductance Catheter
10
Control
Conductance catheterization: CD Leycom Conductance Catheter
5
Total15

Baseline characteristics

CharacteristicIABP RecipientControlTotal
Age, Continuous57 years
STANDARD_DEVIATION 14
54 years
STANDARD_DEVIATION 13
56 years
STANDARD_DEVIATION 13
Body Surface Area (BSA)2.07 m^2
STANDARD_DEVIATION 0.33
2.22 m^2
STANDARD_DEVIATION 0.15
2.12 m^2
STANDARD_DEVIATION 0.28
Region of Enrollment
United States
10 participants5 participants15 participants
Sex: Female, Male
Female
2 Participants2 Participants4 Participants
Sex: Female, Male
Male
8 Participants3 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 5
other
Total, other adverse events
0 / 100 / 5
serious
Total, serious adverse events
0 / 100 / 5

Outcome results

Primary

Impact of Intra-aortic Balloon Pump Activation on Left Ventricular Stroke Work.

We will be measuring left ventricular stroke work using a conductance catheter before and immediately after activation of an intra-aortic balloon pump (IABP). Left ventricular stroke work is quantified as the product of left ventricular pressure and volume. Conductance catheters are the primary method available for clinical measurement of left ventricular volume and pressure.

Time frame: 24 hours

ArmMeasureGroupValue (MEAN)Dispersion
IABP RecipientImpact of Intra-aortic Balloon Pump Activation on Left Ventricular Stroke Work.Stroke work without IABP939 mmHg-mLStandard Deviation 302
IABP RecipientImpact of Intra-aortic Balloon Pump Activation on Left Ventricular Stroke Work.Stroke work with IABP667 mmHg-mLStandard Deviation 210
ControlImpact of Intra-aortic Balloon Pump Activation on Left Ventricular Stroke Work.Stroke work without IABP5628 mmHg-mLStandard Deviation 2866
ControlImpact of Intra-aortic Balloon Pump Activation on Left Ventricular Stroke Work.Stroke work with IABPNA mmHg-mL

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026